(Q37673247)

English

A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity

scientific article published on 12 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

F Montagnani

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

A Chiriatti

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

G Turrisi

3

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

G Francini

4

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

G Fiorentini

5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

12 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Colorectal Disease

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

846-852

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Cancer incidence and mortality in Europe, 2004

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic O

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02206.X

21 January 2018

Identifiers

10.1111/J.1463-1318.2010.02206.X

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37673247&oldid=1721591901"